NCT01098786View on ClinicalTrials.gov

Drug Use Investigation for Cell-culture Derived Influenza A (H1N1) Emulsion HA Vaccine

CompletedOBSERVATIONAL

Enrollment

556

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions

Swine-Origin Influenza A H1N1 Virus

Interventions

BIOLOGICAL

Cell-derived A/H1N1 influenza HA vaccine

Single group vaccinated

Trial Locations (1)

860-0008

National Hospital Organization Kumamoto Medical Center, Chuo-ku

Sponsors

Lead Sponsor

Novartis Vaccines

All Listed Sponsors

lead

Novartis Vaccines

INDUSTRY

NCT01098786 - Drug Use Investigation for Cell-culture Derived Influenza A (H1N1) Emulsion HA Vaccine | Biotech Hunter | Biotech Hunter